Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 170.71B | 155.38B | 100.22B | 79.87B | 88.83B |
Gross Profit | 71.12B | 67.90B | 69.37B | 75.78B | 58.12B |
EBITDA | 21.36B | 17.47B | 23.07B | 31.43B | 17.57B |
Net Income | 12.68B | 9.23B | 14.85B | 21.95B | 11.05B |
Balance Sheet | |||||
Total Assets | 2.35T | 2.41T | 2.42T | 2.29T | 2.26T |
Cash, Cash Equivalents and Short-Term Investments | 498.02B | 506.00B | 580.77B | 541.33B | 638.78B |
Total Debt | 590.56B | 602.18B | 521.15B | 473.63B | 500.73B |
Total Liabilities | 2.14T | 2.21T | 2.21T | 2.09T | 2.06T |
Stockholders Equity | 208.60B | 205.45B | 201.19B | 201.97B | 199.44B |
Cash Flow | |||||
Free Cash Flow | -26.17B | -80.00B | 19.44B | 42.97B | -26.93B |
Operating Cash Flow | -19.67B | -73.42B | 25.07B | 47.09B | -23.49B |
Investing Cash Flow | 86.25B | -8.46B | -79.45B | -110.75B | -92.44B |
Financing Cash Flow | -38.30B | 687.00M | 137.76B | 17.27B | 233.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $219.26B | 11.60 | 10.83% | 7.59% | -1.91% | -6.79% | |
78 Outperform | $262.42B | 13.82 | 11.51% | 1.99% | 0.22% | 19.89% | |
76 Outperform | $150.87B | 12.66 | 9.18% | 2.64% | 5.39% | 20.82% | |
74 Outperform | $809.47B | 14.94 | 16.13% | 2.22% | 4.04% | 8.73% | |
73 Outperform | $174.54B | 13.82 | 6.64% | 2.42% | 0.52% | 89.25% | |
73 Outperform | $356.41B | 13.87 | 9.46% | 2.70% | 3.21% | 20.49% | |
68 Neutral | $16.89B | 11.69 | 9.78% | 3.90% | 11.76% | -7.55% |
On July 1, 2025, Citigroup announced the completion of the Federal Reserve Board’s 2025 annual supervisory stress test, resulting in a reduced Stress Capital Buffer requirement of 3.6% and a preliminary Standardized Common Equity Tier 1 capital ratio requirement of 11.6%. As of March 31, 2025, Citi’s CET1 capital ratio stood at 13.4%, exceeding the regulatory requirement. Citi plans to increase its quarterly common stock dividend and continues its $20 billion share repurchase program, having repurchased $3.75 billion year-to-date. These actions reflect Citi’s strong capital position and strategic focus on returning capital to shareholders.
The most recent analyst rating on (C) stock is a Buy with a $71.00 price target. To see the full list of analyst forecasts on Citigroup stock, see the C Stock Forecast page.
On June 16, 2025, Citigroup‘s Board of Directors elected Jonathan Moulds as an independent director, appointing him to the Risk Management and Transformation Oversight Committees. Moulds, who has a distinguished career in financial services, including roles at Bank of America and Barclays, is expected to enhance Citi’s board with his expertise in global markets and operational efficiency. His appointment is seen as a strategic move to strengthen Citi’s governance and oversight, potentially impacting the company’s operations and industry positioning positively.
The most recent analyst rating on (C) stock is a Buy with a $71.00 price target. To see the full list of analyst forecasts on Citigroup stock, see the C Stock Forecast page.
On April 29, 2025, Citigroup Inc. held its Annual Meeting of Stockholders where several key decisions were made. The stockholders approved an amendment to the Citigroup 2019 Stock Incentive Plan, increasing the authorized shares by 30 million. Additionally, 12 directors were elected, KPMG LLP was ratified as the independent accounting firm for 2025, and the 2024 Executive Compensation was approved. However, several stockholder proposals, including those on golden parachutes, Indigenous Peoples’ rights, climate change, and animal welfare, were not approved.